Cleared Traditional

K221253 - SPOTFIRE RSP Positive Control, SPOTFIRE RSP Negative Control (FDA 510(k) Clearance)

Feb 2023
Decision
277d
Days
Class 2
Risk

K221253 is an FDA 510(k) clearance for the SPOTFIRE RSP Positive Control, SPOTFIRE RSP Negative Control. This device is classified as a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II - Special Controls, product code PMN).

Submitted by Maine Molecular Quality Controls, Inc. (Saco, US). The FDA issued a Cleared decision on February 3, 2023, 277 days after receiving the submission on May 2, 2022.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3920. Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use..

Submission Details

510(k) Number K221253 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2022
Decision Date February 03, 2023
Days to Decision 277 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PMN - Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3920
Definition Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use.